Search Results 81-90 of 17050 for hla genotype

1. A Study to Learn More about How Individuals Process Specific Medications Based on Their Genes in Patients with Gastrointestinal Disorders - Mayo Clinic

   About this study · To evaluate the pharmacogenomic profile (PGx) by genotyping 22 genes, including the CYP2D6 genotype, in patients with functional GI disorders.

2. Clinical trials - Oncology (Medical)

   The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

3. A Study To Evaluate The Efficacy, Safety, And Pharmacokinetics Of Co-Administration Of ABT-493 And ABT-530 With And Without RBV In Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 Or 6 Infection - Mayo Clinic

   HCV genotype performed during screening indicating co-infection with more than one HCV genotype. Participating Mayo Clinic locations. Study statuses change ...

4. A Study to Assess Older Adults Applying Pre-transplant Comorbidity, Geriatric Assessment and Biomarkers to Predict Non-Relapse Mortality After Allogeneic Transplant (CHARM) - Mayo Clinic

   However, the availability of a suitable HLA-matched sibling donor may limit access of this patient population to alloHCT. We retrospectively investigated ...

5. Dent Disease Mutation Genotyping - Clinical Trials

   About this study. This study will help the investigator determine whether certain genetic mutations, more than others, are a cause of more severe disease in ...

6. Clinical trials - Oncology (Medical)

   The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

7. Allogeneic Transplant in HIV Patients (BMT CTN 0903) - Mayo Clinic

   Donor/recipient HLA matching: Related donor ... Unrelated donor: must be a 7/8 or 8/8 match at HLA ... genotype). The results should be included as part ...

8. Study involving investigators from Mayo Clinic, Baylor College of Medicine applies drug-gene testing to improve patient care and reports outcomes

   ... human leukocyte antigen (HLA) region. CYP2D6is involved in the metabolism or processing of up to 25% of all drugs marketed. The HLA region is involved in ...

9. Clinical trials - Oncology (Medical)

   The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

10. A Study of TCD601 in the Induction of Tolerance in de Novo Renal Transplantation (PERSPECTIVE) - Mayo Clinic

    * Recipient of a renal transplant from a non-human leukocyte antigen (HLA)-identical but at least haploidentical, ABO compatible living donor. Key Exclusion ...